{"cmr":"ch-cm-kg/SIX/ADXN","since":null,"total":14,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ch-cm-kg/SIX/ADXN","date":"2026-10-30","event_type":"register_mutation","title":"HR02 Change Addex Therapeutics Ltd, Plan-les-Ouates","reference":"HR02-1006797856","category":"HR02","language":"fr","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/9b44689c-81f1-4fed-8480-2fb3b4d89b21","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006797856; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AFKSq3Ae25RF6FyozeQXUvSgKBTKzFitWKGKwg43sEJ7Ggz9rF0iVF1JTmj2YrIO7k4xGF8mft0df-85p0rkAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2026-10-29","event_type":"newswire_release","title":"ADDEX INCREASES ISSUED SHARE CAPITAL TO CREATE TREASURY","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/29/3390910/0/en/addex-increases-issued-share-capital-to-create-treasury-shares.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9O8uNkeN_lyVQrOt75Qe7g9zyIvyLv4u5hlljEk2bMfWpM9Rj2BO9HvE_i8PtpnwkH0hbp3ytu8L1zEiO5DGCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2026-10-08","event_type":"newswire_release","title":"Addex Spin-Out Neurosterix Completes Phase 1 Clinical","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/08/3376933/0/en/addex-spin-out-neurosterix-completes-phase-1-clinical-studies-of-ntx-253-for-schizophrenia.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"bO8mOZLezn7v9iY_eIlSxIplypC3CR7muQk3SZAD-X9meFeiFM_msJlWL9cuBgrCWyeSHO12KH9j3jrgktlWCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2026-10-02","event_type":"newswire_release","title":"Addex Therapeutics Announces Executive Management ...","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/02/3373503/0/en/addex-therapeutics-announces-executive-management-changes.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ALxCfjM7bDVZzl3uw92CBggvqnt_Fb59Ixy7sEN1Tytq8PaAQTibLV489JNnL5t-reglq4o5KK9g-t8KfVPXDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2026-09-25","event_type":"newswire_release","title":"Addex Regains Rights to GABAB Positive Allosteric Modulator","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/25/3368838/0/en/addex-regains-rights-to-gabab-positive-allosteric-modulator-portfolio-from-indivior.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RQXnFLAJ3fQ2GIWP9ukvKklUCoWn-IGzkjv9c_pLjayxNBtdsj8lZ-7AUkmC9GifL_W_5Rj5pK0cDZq0I6RcDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2026-02-27","event_type":"register_mutation","title":"HR02 Change ADDEX AG, Lützelflüh","reference":"HR02-1006581744","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/b3b04b0a-5ff8-466f-a1ba-82b1f09528b6","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006581744; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-8yASdCRcTRm1SPThFUg0PIYbl5drnWjuIF3XrJ3VbO0ZszGotFPkfU7Qk5VdxV7edDooMFBtItCFIqgCEp6Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2026-02-03","event_type":"newswire_release","title":"Addex Announces Publication of Preclinical Data Supporting","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/02/03/3230712/0/en/Addex-Announces-Publication-of-Preclinical-Data-Supporting-Potential-of-mGlu7-Negative-Allosteric-Modulators-to-Transform-Anxiety-and-Fear-Related-Disorder-Treatment.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PXKJVoCKhINM8Ad-HqGu0nlA_sYD-8ZKpvcGCFGJqkTST5mxVAhEMxehZQhxSzk4Rtjhhxfx_YN-HcrUgkgEDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2026-01-07","event_type":"newswire_release","title":"Addex Spin-Out Neurosterix has started a Phase 1 Clinical","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/01/07/3214260/0/en/Addex-Spin-Out-Neurosterix-has-started-a-Phase-1-Clinical-Study-with-M4-PAM-NTX-253-for-Schizophrenia.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"a2Vj_Q5FZq5BLxwKCUqW8BAQ3Mea5k6qn8n1DbsNAO_gnDT3R-9w91mmuTbiKuzeL0H3ls8FqV9dXQQRDs_PDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2025-12-01","event_type":"results","title":"Addex Therapeutics to Report 2025 Third Quarter Financial","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/de/news-release/2025/12/01/3196636/0/en/Addex-Therapeutics-to-Report-2025-Third-Quarter-Financial-Results-And-Host-Conference-Call-on-December-4-2025.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"f7szVtNlO28bhLeAXF0bggyjqjauEPjXspLg_Bu5xBnMLRYlePU4mPpTaynNQ7Hl9_Mkt5mimWqIRip4hRnGDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2025-12-01","event_type":"results","title":"Addex Therapeutics to Report 2025 Third Quarter Financial","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/01/3196636/0/en/addex-therapeutics-to-report-2025-third-quarter-financial-results-and-host-conference-call-on-december-4-2025.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dBOSkoTZsZ2eme_ndoPzgpdyovD-Qn0-1sJSnmLHRPX5L74kcUgKLJ34shXlbPZoNMVJcOdLHjr-nLG9ob3FDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2025-10-29","event_type":"newswire_release","title":"Addex Increases Issued Share Capital to Create Treasury","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/10/29/3176123/0/en/Addex-Increases-Issued-Share-Capital-to-Create-Treasury-Shares.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1_W6IucBnqdC90ZMVuy1Tec16UeunEI9pemKAS7n7_F53zMZwlFUAwbxm5PrhVvK9B7l1glAh4n9VUm20nhICQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2025-09-30","event_type":"results","title":"Addex Therapeutics Reports 2025 Half Year and Second","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/09/30/3158259/0/en/Addex-Therapeutics-Reports-2025-Half-Year-and-Second-Quarter-Financial-Results-and-Provides-Corporate-Update.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rP0vKvkGPpmxOYBKdAVQcHMgmIusB9VEoXNqsq3YvEGEho2D3wCwB6h2c7ata-7TZJ6AyDz11GEj7XoFLFyDDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2025-09-26","event_type":"results","title":"Addex Therapeutics to Report 2025 Half-year and Second","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/fr/news-release/2025/09/26/3156819/0/en/Addex-Therapeutics-to-Report-2025-Half-year-and-Second-Quarter-Financial-Results-on-September-30-2025-and-Host-Conference-Call-on-October-1-2025.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"YxfgulSJs2gRAGPO2wPT8B4wD8S981FeTJu3LfyqaYFz4Q-mZGf9DHpqh8nGQnsIq6TKNjanWlVKaTgim0SOCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/ADXN","date":"2025-09-26","event_type":"results","title":"Addex Therapeutics to Report 2025 Half-year and Second","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/09/26/3156819/0/en/Addex-Therapeutics-to-Report-2025-Half-year-and-Second-Quarter-Financial-Results-on-September-30-2025-and-Host-Conference-Call-on-October-1-2025.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"U7GEa9in1EQynU5qhYbFFReaNSR85wZ4pfdJuEX3qu4tYMI4KmBF4eFVaGk8kLw3iw8UsUzG_qfs04Kvx1EZBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}